Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders

J Autism Dev Disord. 2022 Mar;52(3):1299-1313. doi: 10.1007/s10803-021-05031-7. Epub 2021 May 10.

Abstract

The clinical similarity among different neuropsychiatric disorders (NPDs) suggested a shared genetic basis. We catalogued 23,109 coding de novo mutations (DNMs) from 6511 patients with autism spectrum disorder (ASD), 4,293 undiagnosed developmental disorder (UDD), 933 epileptic encephalopathy (EE), 1022 intellectual disability (ID), 1094 schizophrenia (SCZ), and 3391 controls. We evaluated that putative functional DNMs contribute to 38.11%, 34.40%, 33.31%, 10.98% and 6.91% of patients with ID, EE, UDD, ASD and SCZ, respectively. Consistent with phenotype similarity and heterogeneity in different NPDs, they show different degree of genetic association. Cross-disorder analysis of DNMs prioritized 321 candidate genes (FDR < 0.05) and showed that genes shared in more disorders were more likely to exhibited specific expression pattern, functional pathway, genetic convergence, and genetic intolerance.

Keywords: Candidate gene; De novo mutation; Expression pattern; Functional network; Neuropsychiatric disorder.

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Intellectual Disability* / genetics
  • Mutation
  • Phenotype
  • Schizophrenia*